tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sensei will not initiate new clinical study for solnerstotug
PremiumThe FlySensei will not initiate new clinical study for solnerstotug
1d ago
Sensei Biotherapeutics Inc trading halted, news pending
Premium
The Fly
Sensei Biotherapeutics Inc trading halted, news pending
1d ago
Buy Rating for Sensei Biotherapeutics: Promising Phase 1/2 Trial Results of Solnerstotug in PD-L1 Resistant Tumors
Premium
Ratings
Buy Rating for Sensei Biotherapeutics: Promising Phase 1/2 Trial Results of Solnerstotug in PD-L1 Resistant Tumors
11d ago
Sensei Biotherapeutics Inc trading resumes
PremiumThe FlySensei Biotherapeutics Inc trading resumes
15d ago
Sensei Biotherapeutics Inc trading halted, volatility trading pause
Premium
The Fly
Sensei Biotherapeutics Inc trading halted, volatility trading pause
15d ago
Sensei Biotherapeutics Inc trading resumes
Premium
The Fly
Sensei Biotherapeutics Inc trading resumes
3M ago
Sensei Biotherapeutics Regains Nasdaq Compliance
PremiumCompany AnnouncementsSensei Biotherapeutics Regains Nasdaq Compliance
4M ago
Sensei price target raised to $35 at Stephens to reflect 1-for-20 reverse split
Premium
The Fly
Sensei price target raised to $35 at Stephens to reflect 1-for-20 reverse split
4M ago
Sensei Biotherapeutics Inc trading halted, news pending
Premium
The Fly
Sensei Biotherapeutics Inc trading halted, news pending
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100